Displaying 5101 - 5150 of 6205 results
Released Company Title Industry Topic
09 Apr 2024
08:00 CEST
GOLDEN ENERGY OFFSHORE SERVICES Golden Energy Offshore Services AS (GEOS) Secures Short Term Contract for Energy Pace 60101030 Oil Equipment and Services Non-regulatory press releases
09 Apr 2024
08:00 CEST
ESSILORLUXOTTICA EssilorLuxottica closes the acquisition of Washin to grow its optical retail presence in Japan 20102015 Medical Supplies Mergers, Acquiqitions, Transferts
09 Apr 2024
08:00 CEST
GE Aerospace Doc re. GE Files 8-K/A 50203000 Diversified Industrials Legal
09 Apr 2024
07:42 CEST
PAYTON PLANAR MAGNETICS PR 2024 04 08 Shareholders' Meeting 50202010 Electrical Components Meetings / events
09 Apr 2024
07:32 CEST
ATOS Point de marché - 9 avril 10101010 Computer Services Other subject
09 Apr 2024
07:32 CEST
ATOS Market Update - April 9 10101010 Computer Services Other subject
09 Apr 2024
07:30 CEST
HUNTER GROUP Hunter Group ASA - Monthly TC-result - March 60101030 Oil Equipment and Services Additional regulated information required to be disclosed under the laws of a Member State
09 Apr 2024
07:30 CEST
KID Kid ASA - Revenues for the First Quarter of 2024 40401025 Home Improvement Retailers Additional regulated information required to be disclosed under the laws of a Member State
09 Apr 2024
07:30 CEST
Boussard Gavaudan BGHL (EUR): NAV(s) 30204000 Closed End Investments Other subject
09 Apr 2024
07:30 CEST
BOUSSARD GAVAUDAN HOLD LTD GBP BGHL (GBP): NAV(s) 30204000 Closed End Investments Other subject
09 Apr 2024
07:15 CEST
BIOMERIEUX bioMérieux presents its new 5-year strategic plan and its targets for profitable growth 20102010 Medical Equipment Other subject
09 Apr 2024
07:15 CEST
BIOMERIEUX bioMérieux présente son nouveau plan stratégique à 5 ans et son objectif de croissance rentable 20102010 Medical Equipment Other subject
09 Apr 2024
07:09 CEST
BORR DRILLING Borr Drilling Limited - Contracting Update 60101030 Oil Equipment and Services Additional regulated information required to be disclosed under the laws of a Member State
09 Apr 2024
07:01 CEST
BIOMERIEUX bioMérieux – First-Quarter 2024 Business Review 20102010 Medical Equipment Other subject
09 Apr 2024
07:01 CEST
BIOMERIEUX bioMérieux – Information financière du 1er trimestre 2024 20102010 Medical Equipment Other subject
09 Apr 2024
07:00 CEST
CIRCIO HOLDING ASA Circio invites to a company update on Wednesday 17 April 2024 20103010 Biotechnology Non-regulatory press releases
09 Apr 2024
07:00 CEST
NORBIT NORBIT ASA - Notice of Annual General Meeting on 6 May 2024 50202040 Electronic Equipment: Other Additional regulated information required to be disclosed under the laws of a Member State
09 Apr 2024
07:00 CEST
NORBIT NORBIT ASA - Annual Report for 2023 50202040 Electronic Equipment: Other Annual financial and audit Reports
09 Apr 2024
07:00 CEST
TGS ASA Q1 2024 Revenue Update 60101030 Oil Equipment and Services Additional regulated information required to be disclosed under the laws of a Member State
09 Apr 2024
07:00 CEST
ONWARD MEDICAL Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00 20101025 Health Services -
09 Apr 2024
07:00 CEST
VGP Convocation to the Annual Shareholders’ Meeting and the Special Shareholders’ Meeting of 10 May 2024 35101010 Real Estate Holding and Development General meeting / Board Meeting
09 Apr 2024
07:00 CEST
PGS PGS ASA: Q1 2024 Update 60101030 Oil Equipment and Services Inside information
09 Apr 2024
07:00 CEST
INNATE PHARMA Innate Pharma annonce sa participation à une prochaine Conférence Investisseurs 20103010 Biotechnology Meetings / events
09 Apr 2024
07:00 CEST
VGP Oproeping tot de Gewone Algemene Vergadering en de Bijzondere Algemene Vergadering van Aandeelhouders van 10 Mei 2024 35101010 Real Estate Holding and Development General meeting / Board Meeting
09 Apr 2024
07:00 CEST
HOEGH AUTOLINERS ASA Höegh Autoliners ASA – New Long-Term Financing Arrangements 50206030 Marine Transportation Non-regulatory press releases
09 Apr 2024
07:00 CEST
INNATE PHARMA Innate Pharma Announces Its Participation in Upcoming Investor Conference 20103010 Biotechnology Meetings / events
09 Apr 2024
07:00 CEST
Link Mobility Group Holding LINK Mobility - Transactions made under Company share repurchase program 10101015 Software Acquisition or disposal of the issuer’s own shares
09 Apr 2024
05:30 CEST
HAFNIA LIMITED Hafnia Limited – Increase in Quarterly Dividend Payout Ratio 50206030 Marine Transportation Inside information
09 Apr 2024
05:27 CEST
HAFNIA LIMITED Hafnia Limited - Commencement of trading and admission to trading on NYSE 50206030 Marine Transportation Additional regulated information required to be disclosed under the laws of a Member State
08 Apr 2024
23:57 CEST
DEUTSCHE TELEKOM Deutsche Telekom AG: Release of a capital market information 15102015 Telecommunications Services Other subject
08 Apr 2024
23:55 CEST
5TH PLANET GAMES 8-2024 5th Planet Games - Notice of annual general meeting 2024 40203045 Toys Additional regulated information required to be disclosed under the laws of a Member State
08 Apr 2024
23:55 CEST
5TH PLANET GAMES 7-2024 5th Planet Games A/S - Annual Report for 2023 40203045 Toys Annual financial and audit Reports
08 Apr 2024
23:12 CEST
BIOPHYTIS Biophytis annonce ses résultats financiers 2023 et fait le point sur ses activités 20103010 Biotechnology Other subject
08 Apr 2024
23:12 CEST
BIOPHYTIS Biophytis announces its 2023 financial results and provides an update on its business activities 20103010 Biotechnology Other subject
08 Apr 2024
23:10 CEST
BIOPHYTIS Biophytis lance l\'étude clinique de phase 2 OBA dans l\'obésité avec BIO101 (20-hydroxyecdysone) 20103010 Biotechnology Other subject
08 Apr 2024
23:10 CEST
BIOPHYTIS Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone) 20103010 Biotechnology Other subject
08 Apr 2024
23:07 CEST
Euronav Luxembourg SA 21/26 6.25pct USD C Fourworld files another request - Additional regulated information required to be disclosed under the laws of a Member State
08 Apr 2024
23:04 CEST
- Biophytis announces its 2023 financial results and provides an update on its business activities - Commercial results
08 Apr 2024
23:04 CEST
- Biophytis annonce ses résultats financiers 2023 et fait le point sur ses activités - Commercial results
08 Apr 2024
23:01 CEST
- Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone) - Commercial results
08 Apr 2024
23:01 CEST
- Biophytis announces its 2023 financial results and provides an update on its business activities - Commercial results
08 Apr 2024
23:00 CEST
- Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone) - Other subject
08 Apr 2024
23:00 CEST
- Biophytis lance l'étude clinique de phase 2 OBA dans l'obésité avec BIO101 (20-hydroxyecdysone) - Other subject
08 Apr 2024
23:00 CEST
EURONAV Fourworld dient nog een verzoek in 50206030 Marine Transportation Other subject
08 Apr 2024
23:00 CEST
EURONAV Fourworld files another request 50206030 Marine Transportation Other subject
08 Apr 2024
22:45 CEST
SALMONES CAMANCHACA S.A. AGM summoning notice 2024 45102010 Farming, Fishing, Ranching and Plantations Additional regulated information required to be disclosed under the laws of a Member State
08 Apr 2024
22:33 CEST
ARCHER Archer Limited: Notice of Annual General Meeting 2024 60101030 Oil Equipment and Services Additional regulated information required to be disclosed under the laws of a Member State
08 Apr 2024
22:30 CEST
CELLECTIS Cellectis présentera deux posters sur un nouveau procédé d’édition par TALEN® pour la correction et l’insertion de gènes dans les cellules souches et progénitrices hématopoïétiques (HSPCs) à l’ASGCT 20103010 Biotechnology -
08 Apr 2024
22:30 CEST
CELLECTIS Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and Gene Insertion in HSPCs at the ASGCT Annual Meeting 20103010 Biotechnology -
08 Apr 2024
22:05 CEST
SEADRILL LIMITED Seadrill Announces Transactions Made Under the Company’s Share Repurchase Program 60101030 Oil Equipment and Services Acquisition or disposal of the issuer’s own shares